Crainic Nicolas, Furtner Julia, Pallud Johan, Bielle Franck, Lombardi Giuseppe, Rudà Roberta, Idbaih Ahmed
Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Service de Neurologie 2, 75013 Paris, France.
Department of Neurology, University Hospital of Brest, 29200 Brest, France.
Cancers (Basel). 2023 Feb 9;15(4):1120. doi: 10.3390/cancers15041120.
Rare glial, neuronal and glioneuronal tumours in adults form a heterogeneous group of rare, primary central nervous system tumours. These tumours, with a glial and/or neuronal component, are challenging in terms of diagnosis and therapeutic management. The novel classification of primary brain tumours published by the WHO in 2021 has significantly improved the diagnostic criteria of these entities. Indeed, diagnostic criteria are nowadays multimodal, including histological, immunohistochemical and molecular (i.e., genetic and methylomic). These integrated parameters have allowed the specification of already known tumours but also the identification of novel tumours for a better diagnosis.
成人罕见的胶质、神经元和胶质神经元肿瘤构成了一组异质性的罕见原发性中枢神经系统肿瘤。这些具有胶质和/或神经元成分的肿瘤在诊断和治疗管理方面具有挑战性。世界卫生组织2021年发布的原发性脑肿瘤新分类显著改善了这些实体的诊断标准。事实上,如今的诊断标准是多模式的,包括组织学、免疫组化和分子(即基因和甲基化组)标准。这些综合参数有助于明确已知肿瘤,也有助于识别新肿瘤以实现更好的诊断。